http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2230872-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
| filingDate | 1999-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deed8712644e67bcada674b4a4c65ada |
| publicationDate | 2005-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2230872-T3 |
| titleOfInvention | TRANSDERMAL PATCH THAT CONTAINS AT LEAST AN ACTIVE PRINCIPLE THAT INFLUENCES THE LEVELS OF LIPIDS IN BLOOD. |
| abstract | Prepared in the form of a transdermal therapeutic system that contains, in a self-adhesive matrix layer capable of coating with a top layer impermeable to the active substance on its face farthest from the skin, at least one active ingredient that influences blood lipid levels and at least one adjuvant promoting the permeation of the active substance through the skin, characterized in that said active ingredient is selected from the group of active principles inhibiting hydroxymethyl glutaryl-CoA reductase, the self-adhesive matrix layer being a mass a polyacrylate base or a silicone-based mass, and said excipient being selected from the group comprising pyrrolidone derivatives, fatty acids, fatty alcohols, fatty acid esters, fatty acid ethers, paraffinic derivatives, terpenes, ethylene glycol monoalkyl ethers , polyoxyethylene alkyl ethers, polyoxyethylene aryl ethers, estere s polyoxyethylene alkyl, polyoxypropylene alkyl ethers, fatty acid and propylene glycol derivatives, glycerin fatty esters, polysorbates, poloxamers, dialkylsulfoxides, urea and its derivatives, glycerin, natural oils, laurocaprams, phospholipids, a-midas, amino acids , N-methylformamide, acetonides, calcium thioglycolate, propylene glycol, polyethylene glycol, alkyl sulfates, sodium lauryl sulfate, tetrahydrofurfuryl alcohol, macrocyclic compounds or polar solvents such as panthenol. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018115535-A1 |
| priorityDate | 1998-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.